Earnings Ahead

ACAD - ACADIA Pharmaceuticals, Inc.

22.17 0.41 1.88

ACADIA Pharmaceuticals, Inc.

ACADIA Pharmaceuticals, Inc.

About

Profile

ACADIA’s history is rooted in science and strong leadership in central nervous system (CNS) research. Since the beginning, we have been dedicated to improving the lives of patients suffering from CNS disorders. We invite you to learn more about our hist


Headquarters

San Diego, California, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

ACAD



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Acadia Pharma GAAP EPS of $0.28 misses by $0.02, revenue of $231.04M beats by $7.24M
  • Minerva falls as FDA rejects schizophrenia therapy
  • Acadia Pharma 2023 Earnings Preview
  • Baird starts Acadia at outperform ahead of Phase 3 data
  • Needham upgrades Acadia to buy, cites physician support for Daybue
  • Top high-quality growth stocks poised to outperform - MS
  • FDA’s new drug approvals for 2023 rise 51% from last year
  • Bristol-Karuna deal: What other biotechs might be in M&A crosshairs?
  • Acadia Pharma ticks lower amid Deutsche Bank downgrade after surge on patent win
  • Acadia Pharmaceuticals surges 32% after win in patent suit over Nuplazid (update)
  • Acadia starts Phase 3 study for Prader-Willi hunger treatment
  • Mizuho turns bullish on Acadia over Daybue prospects
  • Acadia Pharma GAAP EPS of -$0.40 beats by $0.05, revenue of $211.7M beats by $22.08M
  • Acadia Pharma Q3 2023 Earnings Preview
  • Acadia Pharma falls after patent hearing in dispute with MSN
  • Acadia Pharma GAAP EPS of $0.01 beats by $0.07, revenue of $165.3M beats by $7.46M
  • Acadia Pharma Q2 2023 Earnings Preview
  • Biggest stock movers today: UnitedHealth, State Street, Canopy Growth, Ericsson and more
  • Acadia Pharma soars on drug rights deal, updated sales guidance
  • Acadia adds late-stage development candidate for Prader-Willi syndrome to portfolio
Date Price Open High Low Vol Change ER
Oct 9, 2023 21.72 21.48
21.91
21.32
653K 0.18%
Oct 6, 2023 21.68 21.11
21.84
21.03
1.1M -1.28%
Oct 5, 2023 21.96 21.62
22.02
21.48
1.1M 2.04%
Oct 4, 2023 21.52 20.61
21.65
20.6
1.6M 3.56%
Oct 3, 2023 20.78 21.34
21.41
20.66
1.3M -3.21%
 
Oct 2, 2023 21.47 20.69
21.52
20.31
2.4M 3.02%
Sep 29, 2023 20.84 21.64
21.64
20.54
3.0M -3.2%
Sep 28, 2023 21.53 25
25.17
21.16
7.0M -15.83%
Sep 27, 2023 25.58 23.68
26.31
23.19
4.8M 8.25%
Sep 26, 2023 23.63 23.38
23.75
23.2
2.8M 1.46%
Sep 25, 2023 23.29 23.43
23.6
23.08
1.5M -1.15%
Sep 22, 2023 23.56 23.56
23.74
22.97
1.7M 0.68%
Sep 21, 2023 23.4 23.7
23.95
23.27
1.6M -1.64%
Sep 20, 2023 23.79 24.44
24.95
23.76
1.3M -2.66%
Sep 19, 2023 24.44 24.62
24.67
24.05
1.8M 0.08%
Sep 18, 2023 24.42 24.71
25.09
24.18
1.9M -1.21%
Sep 15, 2023 24.72 25.88
25.89
24.67
1.9M -4.37%
Sep 14, 2023 25.85 25.97
26.58
25.6
1.3M -0.15%
Sep 13, 2023 25.89 26.08
26.38
25.64
1.3M -0.96%
Sep 12, 2023 26.14 27.13
27.13
25.91
1.4M -3.65%
Sep 11, 2023 27.13 26.45
27.18
26.22
1.2M 2.57%
Sep 8, 2023 26.45 26.29
26.68
26.23
652K 0.42%
Sep 7, 2023 26.34 26.91
26.92
26.29
791K -2.84%
Sep 6, 2023 27.11 27.57
27.65
26.97
803K -1.67%
Sep 5, 2023 27.57 27.65
27.82
27.14
840K -0.79%
Sep 1, 2023 27.79 27.17
27.85
27.17
926K 2.85%
Aug 31, 2023 27.02 26.99
27.38
26.86
1.1M 0.11%
Aug 30, 2023 26.99 27.17
27.5
26.9
1.1M -0.37%
Aug 29, 2023 27.09 27.87
27.87
26.77
1.6M -2.8%
Aug 28, 2023 27.87 28.56
28.66
27.8
1.0M -2.55%
Aug 25, 2023 28.6 28.52
28.83
28.17
818K 0.70%
Aug 24, 2023 28.4 28.74
28.81
28.26
894K -0.84%
Aug 23, 2023 28.64 29.14
29.35
28.58
902K -1.55%
Aug 22, 2023 29.09 30.3
30.33
29.06
957K -4.06%
Aug 21, 2023 30.32 29.33
30.49
28.75
2.0M 3.38%
Aug 18, 2023 29.33 28.6
29.5
28.49
1.2M 1.49%
Aug 17, 2023 28.9 29.23
29.26
28.66
1.7M -1.2%
Aug 16, 2023 29.25 29.06
29.99
28.92
2.0M 1.85%
Aug 15, 2023 28.72 28.07
28.74
27.76
1.2M 2.53%
Aug 14, 2023 28.01 27.29
28.31
26.57
1.4M 2.34%
Aug 11, 2023 27.37 26.6
27.54
26.56
1.0M 2.70%
Aug 10, 2023 26.65 26.63
26.77
26.28
1.1M 0.23%
Aug 9, 2023 26.59 26.72
26.72
26.1
1.0M -0.49%
Aug 8, 2023 26.72 26.83
27.15
26.44
1.3M -0.3%
Aug 7, 2023 26.8 27.17
27.17
26.52
1.7M -1.43%
Aug 4, 2023 27.19 27.2
27.48
26.95
1.9M -0.04%
Aug 3, 2023 27.2 27.98
28.29
27.04
3.7M -6.85%
Aug 2, 2023 29.2 28.75
29.53
28.71
1.7M 0.90%
Aug 1, 2023 28.94 29.25
29.36
28.66
1.9M -1.03%
Jul 31, 2023 29.24 29.23
29.74
28.91
1.8M 0.69%
Jul 28, 2023 29.04 28.75
29.25
27.9
3.5M 0.07%
Jul 27, 2023 29.02 29.48
29.48
28.82
1.0M -0.48%
Jul 26, 2023 29.16 29.59
29.61
29.02
972K -1.49%
Jul 25, 2023 29.6 29.94
30.26
29.5
1.1M -1.4%
Jul 24, 2023 30.02 30.88
30.93
29.93
1.6M -2.53%
Jul 21, 2023 30.8 31.59
31.6
30.63
2.8M -1.47%
Jul 20, 2023 31.26 31.96
32.29
31.03
2.4M -2.04%
Jul 19, 2023 31.91 33.06
33.13
31.46
2.2M -3.27%
Jul 18, 2023 32.99 33.61
33.99
32.9
2.4M -1.43%
Jul 17, 2023 33.47 32.74
33.74
31.9
3.6M 0%